{"id":"W4415978236","doi":"10.1016/j.ygyno.2025.10.031","title":"Corrigendum to “OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer” [Gynecol Oncol 2025 Jun 197 182–191]","year":2025,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemotherapy; Epithelial ovarian cancer; Gene; Phases of clinical research; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004554287,0.002098387,0.002849714,0.002079279,0.002272513,0.00234607,0.002957973,0.007409909,0.0454512],"category_scores_gemma":[0.02141585,0.001136961,0.002571877,0.001260871,0.001142048,0.0008492226,0.001055391,0.008612778,0.01800353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004754315,"about_ca_system_score_gemma":0.004668356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0354765,"about_ca_topic_score_gemma":0.07323422,"domain_scores_codex":[0.9975415,0.0005799425,0.0003317178,0.0003352438,0.000923033,0.0002885359],"domain_scores_gemma":[0.9910635,0.003401602,0.0004817509,0.0004855474,0.003692191,0.0008753546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.00007517147,0.000018739,0.00004649195,0.00005610926,0.00001919143,0.0001516845,0.000004363923,0.0000213052,0.00003287034,0.0001045847,0.9967297,0.002739723],"study_design_scores_gemma":[0.0004588399,0.0001390767,0.002496418,0.0002594567,0.0002086218,0.0003268709,0.00002192535,0.0003064255,0.0003889605,0.0006573844,0.9946892,0.00004681314],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0001966922,0.002712589,0.0003001318,0.09605367,0.8909451,0.0001710618,0.001309428,0.0002056963,0.00810551],"genre_scores_gemma":[0.004724764,0.006621097,0.001645911,0.3363353,0.4021203,0.0004832624,0.002254819,0.0003613336,0.2454532],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.0454512,"threshold_uncertainty_score":0.1520494,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02424227857204758,"score_gpt":0.3582569080953985,"score_spread":0.3340146295233509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}